Synapse - Gunjan Shah

Results (244)

Comparison of double unit cord blood transplants (dCBT) with 8/8 HLA-allele matched related (MRD) or unrelated donor (MUD) T-cell depleted (TCD) transplants in adults with myeloid malignancies: Comparable progression-free survival (PFS)

Meeting Abstract

Politikos, I.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; O'Reilly, R. J.; Scaradavou, A.; Castro-Malaspina, H.; Dahi, P. B.; Gyurkocza, B.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Engrafting unit-recipient HLA-allele mismatch is not associated with an increased risk of transplant-related mortality (TRM) or inferior progression-free survival (PFS) after double unit cord blood (CB) transplantation (dCBT) in adults with hematologic malignancies

Meeting Abstract

Politikos, I.; Devlin, S. M.; Maloy, M. A.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; Castro-Malaspina, H.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Double-unit cord blood (CB) transplantation (dCBT) supplemented with haplo-identical CD34+ cells may be associated with enhanced neutrophil recovery but successful myeloid bridging is strongly influenced by haplo CD34+ cell dose and haplo-winning CB unit HLA-match

Meeting Abstract

Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M. A.; Naputo, K.; Afuye, A.; Avecilla, S. T.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Evaluation of cord blood (CB) TNC & CD34+ cell content, cell dose & donor-recipient 8-allele HLA-match by patient ancestry: An analysis of 544 units in a racially & ethnically diverse patient population

Meeting Abstract

Mazis, C.; Politikos, I.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; Davis, E.; Cooper, C.; Nhaissi, M.; Suri, B.; Wells, D. S.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Microbiota injury in auto-HCT is frequent, occurs across geography, and is comparable to that observed in allo-HCT

Meeting Abstract

Khan, N.; Peled, J. U.; Gomes, A.; Devlin, S. M.; Rondon Clavo, C.; Clurman, A.; Slingerland, J.; Slingerland, A. E.; Maloy, M. A.; Sung, A. D.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study

Meeting Abstract

Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
Blood (2019)

Fulltext@MSK | Save

Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - A single institution pilot study

Research Letter

Lin, R. J.; Dahi, P. B.; Shahrokni, A.; Sarraf, S.; Korc-Grodzicki, B.; Devlin, S. M.; Maloy, M. A.; Shah, G. L.; Jakubowski, A. A.; Giralt, S. A.
Leukemia and Lymphoma (2019)

Fulltext@MSK | Save

Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)